Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About this market
Medical tourism for low cost glaucoma surgeries to drive market growth. Medical tourism is a concept that is widely being accepted in countries such as India, Mexico, Poland, the UAE, Spain, Turkey, and Thailand. The glaucoma surgery is commonly performed in these countries. The analysts have predicted that the glaucoma surgery devices market will register a CAGR of almost 31% by 2023.
Market Overview
Increasing prevalence of glaucoma
Glaucoma is a chronic condition involving an uncontrolled increase in IOP. Approximately 50 out of every 1,000 people are likely to develop glaucoma at some stage in their lives.
High cost with lack of reimbursements
The high price of glaucoma surgery devices increases the cost burden on end-users.
For the detailed list of factors that will drive and challenge the growth of the glaucoma surgery devices market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Lumenis and Novartis the competitive environment is quite intense. Factors such as the medical tourism for low cost glaucoma surgeries and the increasing prevalence of glaucoma, will provide considerable growth opportunities to glaucoma surgery devices manufactures. ALLERGAN, Carl Zeiss Meditec, Ellex Medical Lasers, Glaukos, Lumenis, and Novartis are some of the major companies covered in this report.
Medical tourism for low cost glaucoma surgeries to drive market growth. Medical tourism is a concept that is widely being accepted in countries such as India, Mexico, Poland, the UAE, Spain, Turkey, and Thailand. The glaucoma surgery is commonly performed in these countries. The analysts have predicted that the glaucoma surgery devices market will register a CAGR of almost 31% by 2023.
Market Overview
Increasing prevalence of glaucoma
Glaucoma is a chronic condition involving an uncontrolled increase in IOP. Approximately 50 out of every 1,000 people are likely to develop glaucoma at some stage in their lives.
High cost with lack of reimbursements
The high price of glaucoma surgery devices increases the cost burden on end-users.
For the detailed list of factors that will drive and challenge the growth of the glaucoma surgery devices market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Lumenis and Novartis the competitive environment is quite intense. Factors such as the medical tourism for low cost glaucoma surgeries and the increasing prevalence of glaucoma, will provide considerable growth opportunities to glaucoma surgery devices manufactures. ALLERGAN, Carl Zeiss Meditec, Ellex Medical Lasers, Glaukos, Lumenis, and Novartis are some of the major companies covered in this report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
